Stocky turns companies like Sionna Therapeutics, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Sionna Therapeutics, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show if the company is spending money wisely and making progress on its goals.
Press releases share important news that can affect the company's value and future prospects.
Shareholders vote on company leadership and major decisions; 45.1 million shares were voting.
Quarterly earnings show if the company is spending money wisely and making progress on its goals.
Press releases share important news that can affect the company's value and future prospects.
Annual earnings show the company's total progress, profitability, and financial health over one year.
Press releases share important news that can affect the company's value and future prospects.
Stocky reads Sionna Therapeutics, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Sionna Therapeutics, Inc.'s most recent tracked filing was a 10-Q on 6 Aug 2026: Company reports second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
This page is just a preview. Open the live, interactive version for the full picture:
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.